Abstract:Acute liver failure and metabolic liver disorder animal models have demonstrated that hepatocytes transplanted into the liver or spleen survive and participate in the liver repopulation process, and recent studies have documented the usefulness of hepatocyte transplantation in humans. However, despite the promising cell therapy, there are still many restrictions, such as the shortage of donor human livers and the limited lifespan and the functional insufficiency of primary cultured hepatocytes. The immortalized and highly differentiated human hepatocyte could provide an unlimited supply of transplantable cells. In this study, we established an efficient and highly differentiated immortalized human hepatocyte line for bioartificial liver and hepatocyte transplantation research. Hepatocytes isolated from the liver of a 25 year old, brain dead male were transfected with pcDNA3.1 (-) recombinant plasmid containing the genes encoding simian virus 40 (SV40) large tumor antigen. One of the hepatocyte clones, HepLL, displayed highly differentiated liver functions with immortalized characteristics and was selected with a 700-300 μ g/ml of G418 technique in 42 days. To characterize this immortalized cell line for cell therapy in the near future, HepLL cells were studied with immunohistochemistry, reverse transcription-polymerase chain reactions, immunoblotting, and tumorigenicity tests. The results revealed that HepLL cells displayed morphologic characteristics of liver parenchymal cells, secreted albumin, synthesized urea and glycogen, and expressed liver enriched functional markers, but there were no tumorigenic qualities after transplantation into severe combined immunodeficiency mice. Thus this immortalized human hepatocyte line is expected to be a useful tool for studying the functions of differentiated human hepatocyte and a promising strategy to resolve the shortages of donor organs and the limits of primary human hepatocyte for transplantation and bioartificial liver support systems.

The Study on Construction of Chimeric Hepatocyte Specific Promoter with Different Amount of Enhancers and Its Experimental Investigation in Vitro

Improvement of Human AFP Promoter Efficiency by CMV Early Enhancer

Cloning of Several Tumor-Specific Promoters and of Their Activities Comparison in Human Hepatocellular Carcinoma Cells

Construction of a general albumin promoter reporter system for real-time monitoring of the differentiation status of functional hepatocytes from stem cells in mouse, rat and human.

Study of cancer-specific chimeric promoters induced by irradiation

Study on the Effect of Human CMV Early Transcriptional Enhancer on Human CEA Promoter

Functional Assessment of Expression of Cre Recombinase Targeting the Liver of Transgenic Mice Regulated by Tet-on and Cre/loxP System

Establishment Of Highly Differentiated Immortalized Human Hepatocyte Line With Simian Virus 40 Large Tumor Antigen For Liver Based Cell Therapy

Cloning and promoter activity of rat Smad1 5′-flanking region in rat hepatic stellate cells

A Novel Approach for Inducing Enhanced and Selective Transgene Expression in Hepatocellular-Carcinoma Cells

Construction of LAPTM4B promoter- luciferase reporter recombinants

Expansion and Differentiation of Human Hepatocyte-Derived Liver Progenitor-Like Cells and Their Use for the Study of Hepatotropic Pathogens

Construction of Two Different Recombinant Plasmids Containing Human Telomerase Reverse Transcriptase Gene Promoter

Development of Chimeric Gene Regulators for Cancer-specific Gene Therapy with both Transcriptional and Translational Targeting

Structural and SP1-binding Analysis of Promoter of LAPTM4β, A Novel Gene Associated with Hepatocellular Carcinoma

Incorporation of Prokaryotic Enhancer for Enhancement of Gene Expression Driven by Htert Promoter

Enhancement Of Biodemulsifier Produced By Alkaliphilic Alcali-Genes Sp S-Xj-1 By Ph Optimization And Waste Edible Oil Supplementation Strategy

Up-regulating effect of human hepatitis C virus core protein-binding protein 6 on NACA gene promoter

Construction of an Engineering Chimeric Antibody Against Human Hepatoma and Stable Expression in Sp2/0 Cell

Development of a Gene Therapy Strategy to Target Hepatocellular Carcinoma Based Inhibition of Protein Phosphatase 2A Using the Α-Fetoprotein Promoter Enhancer and Pgk Promoter: an in Vitro and in Vivo Study

ESTABLISHMENT OF CHO CELL STRAIN THAT CAN HIGHLY EFFICIENTLY EXPRESS HEPATOMA ASSOCIATE ANTIGEN HAb18G